Frontiers | Determinants of Serum Immunoglobulin Levels: A Systematic Review and Meta-Analysis
Immunoassay for quantification of antigen-specific IgG fucosylation - eBioMedicine
Performance evaluation of four type-specific commercial assays for detection of herpes simplex virus type 1 antibodies in a Middle East and North Africa population - ScienceDirect
Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19 | NEJM
Frontiers | Evaluation of Patient IgM and IgG Reactivity Against Multiple Antigens for Improvement of Serodiagnostic Testing for Early Lyme Disease
Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study - The Lancet Microbe
Pan-HSV-2 IgG Antibody in Vaccinated Mice and Guinea Pigs Correlates with Protection against Herpes Simplex Virus 2 | PLOS ONE
Immunoglobulin test results: When to take action and when to provide reassurance | New Zealand Doctor
SARS CoV 2 Antibody Testing | Quest Diagnostics
Cells | Free Full-Text | Differences in the Concentration of Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 Recovery or Post-Vaccination
Detection of IgM and IgG antibodies in patients with coronavirus disease 2019 - Hou - 2020 - Clinical & Translational Immunology - Wiley Online Library
Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan | Scientific Reports
EDTA-K2 Improves the Detection Sensitivity of SARS-CoV-2 IgM and IgG A | IJN
Normal Serum Levels of IgG, IgA, IgM, IgD, and IgE in Saudi Arabia | Annals of Saudi Medicine
EDTA-K2 Improves the Detection Sensitivity of SARS-CoV-2 IgM and IgG A | IJN
Immunoglobulin levels by age groups | Download Table
Detection of IgM and IgG antibodies in patients with coronavirus disease 2019 - Hou - 2020 - Clinical & Translational Immunology - Wiley Online Library
Frontiers | Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset
Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults | Communications Medicine
Clinical Value of SARS-CoV2 IgM and IgG Antibodies in Diagnosis of COV | JIR
Dynamic changes and prevalence of SARS-CoV-2 IgG/IgM antibodies: Analysis of multiple factors - ScienceDirect
Antibody Testing: IgG and IgM explained - YouTube
Simoa Semi-Quantitative SARS-CoV-2 IgG Antibody Test - Instructions for Use
VeraSTAT-V | Foal IgG | Randox Laboratories
Clinical Value of SARS-CoV2 IgM and IgG Antibodies in Diagnosis of COV | JIR
